Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:02:18 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Z:MNK - MALLINCKRODT PLC - http://www.mallinckrodt.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MNK - ZHALTED0.3402    18.10  0.30Aug 25-23Jan 2115 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-21 07:30U:MNKNews ReleaseKeenova Marks 100K Peyronie's Disease Patients--a Major Milestone for an Often-Stigmatized Men's Health Condition
2026-01-13 16:45U:MNKNews ReleaseKeenova Announces New Dupuytren's Contracture Survey Presentation About Patient Perceptions and Treatment Outcomes
2025-11-12 16:00U:MNKNews ReleaseKeenova to Participate in the Jefferies Global Healthcare Conference in London
2025-11-10 07:00U:MNKNews ReleaseMallinckrodt Reports Third Quarter 2025 Financial Results
2025-11-10 06:30U:MNKNews ReleaseMallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
2025-10-31 08:00U:MNKNews ReleaseMallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
2025-10-23 08:00U:MNKNews ReleaseMallinckrodt plc to Report Third Quarter 2025 Financial Results on November 10, 2025
2025-10-14 07:00U:MNKNews ReleaseMallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day
2025-09-18 06:45U:MNKNews ReleaseMallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar(TM) Gel (repository corticotropin injection)
2025-08-06 06:45U:MNKNews ReleaseMallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
2025-08-06 06:30U:MNKNews ReleaseMallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance
2025-08-04 08:00U:MNKNews ReleaseMallinckrodt Names Leslie Donato to Board of Directors
2025-08-01 07:00U:MNKNews ReleaseMallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
2025-07-22 06:45U:MNKNews ReleaseMallinckrodt plc to Report Earnings Results for Second Quarter 2025
2025-06-18 06:48U:MNKNews ReleaseMallinckrodt Announces Publication of Real-World Insights on Patient Experience with Acthar(TM) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
2025-06-09 08:30U:MNKNews ReleaseMallinckrodt, Endo Announce Planned Leadership Team for Merged Company
2025-05-14 06:52U:MNKNews ReleaseMallinckrodt Presents Data on Real-World Outcomes with Acthar(TM) Gel (repository corticotropin injection) at the International Congress on Systemic Lupus Erythematosus (LUPUS 2025)
2025-05-13 08:00U:MNKNews ReleaseMallinckrodt and Endo Announce Significant Progress in Proposed Merger
2025-05-06 06:45U:MNKNews ReleaseMallinckrodt plc Reports First Quarter 2025 Financial Results and Reaffirms Full-Year Guidance
2025-04-23 06:52U:MNKNews ReleaseMallinckrodt to Present Data on TERLIVAZ(TM) (terlipressin) for Injection at the 2025 Digestive Disease Week (DDW) Annual Meeting